Author details

Full Name

Markus Graefen

Affiliation

University Hospital Frankfurt, Goethe University Frankfurt am Main

ORCID

Career Start Year

1993

Papers

872

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37775340	Survival of patients with clear cell renal carcinoma according to number and location of organ-specific metastatic sites.	Urol Oncol	2024
37507248	Multi-institutional Development and External Validation of a Machine Learning Model for the Prediction of Distant Metastasis in Patients Treated by Salvage Radiotherapy for Biochemical Failure After Radical Prostatectomy.	Eur Urol Focus	2024
37690970	Overall Survival of Metastatic Prostate Cancer Patients According to Location of Visceral Metastatic Sites.	Clin Genitourin Cancer	2024
35182370	Race/Ethnicity may be an Important Predictor of Life Expectancy in Localized Prostate Cancer Patients: Novel Analyses Using Social Security Administration Life Tables.	J Racial Ethn Health Disparities	2023
37558516	Conditional survival of stage III non-seminoma testis cancer patients.	Urol Oncol	2023
38011867	Impact of Intraoperative Fluctuations of Cardiac Output on Cerebrovascular Autoregulation: An Integrative Secondary Analysis of Individual-level Data.	J Neurosurg Anesthesiol	2023
37661459	Prostate Cancer-specific and All-cause Mortality After Robot-assisted Radical Prostatectomy: 20 Years' Report from the European Association of Urology Robotic Urology Section Scientific Working Group.	Eur Urol Oncol	2023
37483849	The association of the type and number of D'Amico high-risk criteria with rates of pathologically non-organ-confined prostate cancer.	Cent European J Urol	2023
37515651	Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS support.	World J Urol	2023
37894375	EAU Biochemical Recurrence Risk Classification and PSA Kinetics Have No Value for Patient Selection in PSMA-Radioguided Surgery (PSMA-RGS) for Oligorecurrent Prostate Cancer.	Cancers (Basel)	2023
37783172	Differences in long-term continence rates between prostate cancer patients with extraprostatic vs. organ-confined disease undergoing robotic-assisted radical prostatectomy: An observational studys.	Clinics (Sao Paulo)	2023
37831123	Comparative analysis of robot-assisted and open approach for PSMA-radioguided surgery in recurrent prostate cancer.	Eur J Nucl Med Mol Imaging	2023
37541904	Navigating Nomograms To Identify Prostate Cancer Patients for Lymph Node Dissection.	Eur Urol Oncol	2023
35459985	Full functional-length urethral sphincter- and neurovascular bundle preservation improves long-term continence rates after robotic-assisted radical prostatectomy.	J Robot Surg	2023
35718637	Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via Prostate-specific Membrane Antigen-radioguided Surgery.	Eur Urol	2023
36948042	Regional differences in total hospital costs for radical cystectomy in the United States.	Surg Oncol	2023
37450007	Outcome of patients with epithelialized cavity formation after excessive vesicourethral anastomotic leak post radical prostatectomy.	World J Urol	2023
37175005	External Tertiary-Care-Hospital Validation of the Epidemiological SEER-Based Nomogram Predicting Downgrading in High-Risk Prostate Cancer Patients Treated with Radical Prostatectomy.	Diagnostics (Basel)	2023
36976227	New Bioactive Î²-Resorcylic Acid Derivatives from the Alga-Derived Fungus <i>Penicillium antarcticum</i> KMM 4685.	Mar Drugs	2023
37374357	Impact of Age on Long-Term Urinary Continence after Robotic-Assisted Radical Prostatectomy.	Medicina (Kaunas)	2023
37370733	Oncologic Outcomes of Lymph Node Dissection at Salvage Radical Prostatectomy.	Cancers (Basel)	2023
37464963	Real-world evidence of outcomes of oligometastatic hormone-sensitive prostate cancer patients treated with metastasis-directed therapy.	Prostate	2023
36857638	Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death.	J Clin Oncol	2023
36656332	Histopathological results of radical prostatectomy specimen of men younger than 50Â years of age at the time of surgery: possible implications for prostate cancer screening programs?	World J Urol	2023
36656126	Automated Ki-67 labeling index assessment in prostate cancer using artificial intelligence and multiplex fluorescence immunohistochemistry.	J Pathol	2023
36882338	Adenocarcinoma of the Bladder: Assessment of Survival Advantage Associated With Radical Cystectomy and Comparison With Urothelial Bladder Cancer.	Urol Oncol	2023
36813873	Differences in overall survival of T2N0M0 bladder cancer patients vs. population-based controls according to treatment modalities.	Int Urol Nephrol	2023
36919872	The association of type and number of high-risk criteria with cancer specific mortality in prostate cancer patients treated with radiotherapy.	Prostate	2023
36473471	The effect of chemotherapy in sarcomatoid bladder cancer patients treated with radical cystectomy.	Can Urol Assoc J	2023
36877230	[The interoperability of IIEF-5 with EPIC-26 : Sexual function after radical prostatectomy].	Urologie	2023
36868922	Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate Cancer.	Eur Urol Oncol	2023
36906483	The Association Between Cytoreductive Nephrectomy and Overall Survival in Metastatic Renal Cell Carcinoma with Primary Tumor Size â¿¤4Â cm.	Eur Urol Focus	2023
36765653	Survival of Testicular Pure Teratoma vs. Mixed Germ Cell Tumor Patients in Primary Tumor Specimens across All Stages.	Cancers (Basel)	2023
36899091	Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis.	Prostate Cancer Prostatic Dis	2023
36662227	New Marine Fungal Deoxy-14,15-Dehydroisoaustamide Resensitizes Prostate Cancer Cells to Enzalutamide.	Mar Drugs	2023
36239810	Effect of inguinal lymph node dissection in lymph node negative patients with squamous cell carcinoma of the penis.	World J Urol	2023
36192262	Radical cystectomy in non-metastatic sarcomatoid bladder cancer: A direct comparison vs urothelial bladder cancer.	Eur J Surg Oncol	2023
36184537	Targeted Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Biopsy for Quantitative Gleason 4 Grading Prediction in Radical Prostatectomy Specimens: Implications for Active Surveillance Candidate Selection.	Eur Urol Focus	2023
34334344	Nomogram Predicting Downgrading in National Comprehensive Cancer Network High-risk Prostate Cancer Patients Treated with Radical Prostatectomy.	Eur Urol Focus	2022
37521449	Racial/ethnic disparities in the distribution and effect of type and number of high-risk criteria on mortality in prostate cancer patients treated with radiotherapy.	Arab J Urol	2022
35508792	Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity.	Int Urol Nephrol	2022
35348869	Impact of obesity on perioperative, functional and oncological outcomes after robotic-assisted radical prostatectomy in a high-volume center.	World J Urol	2022
35838831	Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patients.	Int Urol Nephrol	2022
35610060	Cancer-specific mortality in patients with non-metastatic renal cell carcinoma who have undergone a nephrectomy and are eligible for adjuvant pembrolizumab.	Semin Oncol	2022
35403734	Contemporary seminal vesicle invasion rates in NCCN high-risk prostate cancer patients.	Prostate	2022
35344221	Impact of positive surgical margin length and Gleason grade at the margin on oncologic outcomes in patients with nonorgan-confined prostate cancer.	Prostate	2022
35501610	Pan-segmental intraprostatic lesions involving mid-gland and apex of prostate (mid-apical lesions): assessing the true value of extreme apical biopsy cores.	World J Urol	2022
35605557	Metastatic stage vs complications at radical nephrectomy with inferior vena cava thrombectomy.	Surg Oncol	2022
35431135	Survival trends in chemotherapy exposed metastatic bladder cancer patients and chemotherapy effect across different age, sex, and race/ethnicity.	Urol Oncol	2022
35661361	Outcomes of robotic-assisted versus open radical cystectomy in a large-scale, contemporary cohort of bladder cancer patients.	J Surg Oncol	2022

1 - 50 of 872

Sebastiaan Remmers

Erasmus MC Cancer Institute, University Medical Center Rotterdam

Career Start Year 2018

Number of shared co-authors 12

Giovanni Motterle

Mayo Clinic

Career Start Year 2017

Number of shared co-authors 14

Adam B Weiner

Northwestern University Feinberg School of Medicine

Career Start Year 2013

Number of shared co-authors 8

Francesco Pellegrino

Urological Research Institute, IRCCS San Raffaele Hospital

Career Start Year 2012

Number of shared co-authors 6

Devin N Patel

university of california san diego School of Medicine

Career Start Year 2011

Number of shared co-authors 2

Izak Faiena

Columbia University Medical Center

Career Start Year 2010

Number of shared co-authors 1

Daniel E Spratt

University Hospitals Seidman Cancer Center, Case Western Reserve University

Career Start Year 2010

Number of shared co-authors 40

Jeffrey J Tosoian

Vanderbilt University Medical Center

Career Start Year 2008

Number of shared co-authors 19

Michael A Liss

University of Texas Health San Antonio

Career Start Year 2008

Number of shared co-authors 6

Alastair D Lamb

University of Oxford

Career Start Year 2007

Number of shared co-authors 15

Jonathan L Wright

University of Washington Medical Center

Career Start Year 2005

Number of shared co-authors 7

Marco Randazzo

Winterthur Cantonal Hospital

Career Start Year 2005

Number of shared co-authors 9

Edward Rowe

Bristol Urological Institute, Southmead Hospital

Career Start Year 2004

Number of shared co-authors 6

Alejandro Berlin

University of Toronto, Princess Margaret Cancer Centre

Career Start Year 2004

Number of shared co-authors 35

Ashley E Ross

Northwestern University

Career Start Year 2003

Number of shared co-authors 28

Tim Dudderidge

University Hospital Southampton NHS Foundation Trust

Career Start Year 2002

Number of shared co-authors 6

Jun Hyuk Hong

Asan Medical Center, University of Ulsan College of Medicine

Career Start Year 2002

Number of shared co-authors 1

Hyun Moo Lee

Samsung Medical Center, Sungkyunkwan University School of Medicine

Career Start Year 2000

Number of shared co-authors 0

Declan Cahill

Royal Marsden Hospital NHS Trust

Career Start Year 1999

Number of shared co-authors 8

Vincent J Gnanapragasam

University of Cambridge

Career Start Year 1999

Number of shared co-authors 15

Niall M Corcoran

Royal Melbourne Hospital, The University of Melbourne

Career Start Year 1997

Number of shared co-authors 23

Todd M Morgan

University of Michigan ann arbor

Career Start Year 1997

Number of shared co-authors 27

Inge M van Oort

Radboud University Medical Center

Career Start Year 1995

Number of shared co-authors 23

Choung-Soo Kim

Asan Medical Center, University of Ulsan College of Medicine

Career Start Year 1993

Number of shared co-authors 3

Antonio Finelli

Princess Margaret Cancer Centre, University Health Network and University of Toronto

Career Start Year 1993

Number of shared co-authors 31

Alexandre R Zlotta

University Health Network, Princess Margaret Cancer Center, University of Toronto

Career Start Year 1993

Number of shared co-authors 22

Byung Ha Chung

Yonsei University College of Medicine and Gangnam Severance Hospital

Career Start Year 1992

Number of shared co-authors 10

Christopher P Evans

University of California Davis

Career Start Year 1988

Number of shared co-authors 29

Philip Cornford

Liverpool University Hospitals

Career Start Year 1988

Number of shared co-authors 11

Joseph L Chin

University of Western Ontario

Career Start Year 1982

Number of shared co-authors 14

row(s) 1 - 30 of 30

Hartwig Huland

Martini-Klinik Prostate Cancer Center, University Hospital-Hamburg-Eppendorf

Co-authored papers 361

Derya Tilki

Universitatsklinikum Hamburg-Eppendorf

Co-authored papers 203

Thorsten Schlomm

Charite - University Hospital Berlin

Co-authored papers 199

Alberto Briganti

IRCCS San Raffaele Scientific Institute

Co-authored papers 195

Fred Saad

University of Montreal Health Center

Co-authored papers 155

Guido Sauter